fig3

Topical rapamycin for angiofibromas in patients with tuberous sclerosis: how does it work in clinical practice?

Figure 3. Patient 8. (A) 3 months after CO2 laser and before rapamycin; (B) 3 months after CO2 laser and before rapamycin close-up; (C) after 6 weeks on rapamycin; (D) after 9 months with topical rapamycin; (E) after 9 months on topical rapamycin close-up; (F) after 2 years

Plastic and Aesthetic Research
ISSN 2349-6150 (Online)   2347-9264 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/